Literature DB >> 25577990

Notes from the field: acute flaccid myelitis among persons aged ≤21 years - United States, August 1-November 13, 2014.

.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25577990      PMCID: PMC4646045     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
In August 2014, physicians at Children’s Hospital Colorado in Aurora, Colorado, noted a cluster of cases of acute limb weakness among children (1). Most patients were found to have distinctive abnormalities of the central spinal cord (i.e., gray matter) on magnetic resonance imaging, and most reported a respiratory or febrile illness preceding the onset of neurologic symptoms. On September 12, the Colorado Department of Public Health and Environment alerted CDC about this cluster. These cases coincided with a national outbreak of severe respiratory disease among children caused by enterovirus D68 (EV-D68) (2). On September 26, CDC issued a health advisory requesting state and local health departments to report cases and send specimens to CDC for testing (3). A case was defined as acute onset of focal limb weakness occurring on or after August 1, 2014, and a magnetic resonance image showing a spinal cord lesion largely restricted to gray matter in a patient aged ≤21 years. As of November 13, CDC had verified reports of 88 cases in 32 states (Figure). The median age of patients was 7.6 years (range = 5 months–20 years), and 54 (61%) were males. Limb weakness was asymmetrical in most patients. Cranial nerve motor dysfunction was reported in 30 (34%) cases. Six (7%) patients had altered mental status, and three (3%) had seizures. Most patients reported a respiratory illness (81%), a febrile illness (68%), or both, occurring before neurologic symptom onset; 8% had neither condition. Among 86 patients for whom past medical history was reported, 65 (76%) were previously healthy, and 21 (24%) had underlying illnesses, most commonly asthma (nine [10%]). All but one patient was hospitalized because of neurologic illness, and 17 (19%) required ventilator support. Among 80 patients from whom cerebrospinal fluid was obtained, 68 (85%) showed a moderate pleocytosis and normal or mildly elevated protein. Information regarding current clinical status was reported for 77 patients (median follow-up = 19 days). Of those, 49 (64%) reported some symptom improvement, and 28 (36%) showed no improvement; none were fully recovered. No deaths were reported.
FIGURE

Number of confirmed cases of neurologic illness with limb weakness (N = 87), by week of onset — United States, August 1–November 13, 2014*

* Exact onset date was not reported for one case (for this case the neurologic symptom onset was reported in an unspecified date during the last week of September).

Among 71 patients with cerebrospinal fluid testing performed by their health care providers, state and local public health departments, or CDC, no enteroviruses or other pathogens have been confirmed to date. Among 41 patients whose upper respiratory tract samples were available for enterovirus/rhinovirus testing at CDC, 17 (41%) tested positive: eight (20%) for EV-D68 and nine (22%) for eight other enterovirus/rhinovirus types. Of the 19 patients whose upper respiratory tract samples were obtained <14 days from respiratory illness onset, 10 (53%) were positive: seven (37%) for EV-D68 and three (16%) for rhinoviruses. Laboratory testing for other pathogens is ongoing. On November 7, CDC published interim clinical management considerations, summarizing expert opinion based on current evidence on management and care of children with acute flaccid myelitis (4). CDC continues to collaborate with partners nationally to investigate reported cases, risk factors, and possible etiologies of this condition. Although the specific causes of this illness are still under investigation, and causal relationship to EV-D68 has not yet been substantiated, being up to date on all recommended vaccinations is essential to prevent a number of severe diseases. Vaccine-preventable diseases include poliomyelitis, which is caused by poliovirus; infection with this enterovirus can present with acute flaccid paralysis. There are also numerous other vaccine-preventable diseases that can result in severe illness. Prevention of viral infections includes general hygienic measures, such as frequent hand washing with soap and water, avoiding close contact with sick persons, and disinfecting frequently touched surfaces. Additional information is available at http://www.cdc.gov/flu/protect/habits/index.htm. If a child appears to have a sudden onset of weakness in arms or legs, caregivers should contact a health care provider to have the child assessed for possible neurologic illness. Health care providers are encouraged to report patients meeting the case definition to their state or local health department. Health departments should report patients with illness meeting the case definition to CDC using a brief patient summary form* and may contact CDC by e-mail to arrange further laboratory testing (limbweakness@cdc.gov). Additional information is available at http://www.cdc.gov/ncird/investigation/viral/sep2014.html.
  2 in total

1.  Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014.

Authors:  Daniel M Pastula; Negar Aliabadi; Amber K Haynes; Kevin Messacar; Teri Schreiner; John Maloney; Samuel R Dominguez; Emily Spence Davizon; Eyal Leshem; Marc Fischer; W Allan Nix; M Steven Oberste; Jane Seward; Daniel Feikin; Lisa Miller
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-10-10       Impact factor: 17.586

2.  Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014.

Authors:  Claire M Midgley; Mary Anne Jackson; Rangaraj Selvarangan; George Turabelidze; Emily Obringer; Daniel Johnson; B Louise Giles; Ajanta Patel; Fredrick Echols; M Steven Oberste; W Allan Nix; John T Watson; Susan I Gerber
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-12       Impact factor: 17.586

  2 in total
  28 in total

1.  A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study.

Authors:  Alexander L Greninger; Samia N Naccache; Kevin Messacar; Anna Clayton; Guixia Yu; Sneha Somasekar; Scot Federman; Doug Stryke; Christopher Anderson; Shigeo Yagi; Sharon Messenger; Debra Wadford; Dongxiang Xia; James P Watt; Keith Van Haren; Samuel R Dominguez; Carol Glaser; Grace Aldrovandi; Charles Y Chiu
Journal:  Lancet Infect Dis       Date:  2015-03-31       Impact factor: 25.071

2.  Comparative assessment of seller's staining test (SST) and direct fluorescent antibody test for rapid and accurate laboratory diagnosis of rabies.

Authors:  Ishaya S Tekki; Zhakum N Ponfa; Chika I Nwosuh; Peterside R Kumbish; Clement L Jonah; Philip A Okewole; David Shamaki; Sani M Ahmed
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  MRI Atlas-Based Measurement of Spinal Cord Injury Predicts Outcome in Acute Flaccid Myelitis.

Authors:  D B McCoy; J F Talbott; Michael Wilson; M D Mamlouk; J Cohen-Adad; Mark Wilson; J Narvid
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-15       Impact factor: 3.825

4.  Evaluation of a Real-Time Reverse Transcription-PCR Assay for Detection of Enterovirus D68 in Clinical Samples from an Outbreak in New York State in 2014.

Authors:  Jian Zhuge; Eric Vail; Jeffrey L Bush; Lauren Singelakis; Weihua Huang; Sheila M Nolan; Janet P Haas; Helen Engel; Millicent Della Posta; Esther C Yoon; John T Fallon; Guiqing Wang
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

Review 5.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

Review 6.  Acute flaccid myelitis: A clinical review of US cases 2012-2015.

Authors:  Kevin Messacar; Teri L Schreiner; Keith Van Haren; Michele Yang; Carol A Glaser; Kenneth L Tyler; Samuel R Dominguez
Journal:  Ann Neurol       Date:  2016-08-04       Impact factor: 10.422

7.  Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.

Authors:  Alison M Hixon; Penny Clarke; Kenneth L Tyler
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

8.  Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance.

Authors:  James J Sejvar; Adriana S Lopez; Margaret M Cortese; Eyal Leshem; Daniel M Pastula; Lisa Miller; Carol Glaser; Anita Kambhampati; Kayoko Shioda; Negar Aliabadi; Marc Fischer; Nicole Gregoricus; Robert Lanciotti; W Allan Nix; Senthilkumar K Sakthivel; D Scott Schmid; Jane F Seward; Suxiang Tong; M Steven Oberste; Mark Pallansch; Daniel Feikin
Journal:  Clin Infect Dis       Date:  2016-06-17       Impact factor: 9.079

Review 9.  The epidemiology of non-polio enteroviruses: recent advances and outstanding questions.

Authors:  Margarita Pons-Salort; Edward P K Parker; Nicholas C Grassly
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

10.  What happened to enterovirus D68 infections in 2015?

Authors:  D Harris; S Desai; M Smieja; C Rutherford; D Mertz; J M Pernica
Journal:  Can Commun Dis Rep       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.